Abstract
Around 70% of the Latvian pharmaceutical market is supplied by imports. The
European Regional Development Fund and the Latvian government are currently
funding the National Programme in the Area of Healthcare 2004-2006, worth 11.3
million lats (US$6.1 million). This report is ideal for executives wanting to
understand the key drivers in the pharmaceutical market and have access to a
wealth of statistical data, including five-year market projections. Included
with the report are 3 free quarterly updated outlook reports, enabling you to
keep up to date with market developments for a year.
Latvia is one of the smallest countries in Europe. It joined the EU in May
2004 and NATO two months earlier. The 2006 population is estimated to be 2.3
million, with the most populous city being Riga, the capital. As with other
European countries, Latvia has an ageing population, with those aged 65 and
over representing 16.5% of the population in 2006, compared to 14.5% in 1999.
Funding for healthcare in Latvia is managed by the State Compulsory Health
Insurance Agency, although funds are gathered largely through general
taxation. Treatments guaranteed to all Latvians and foreign residents include
emergency care, treatment for acute and chronic diseases, maternity care,
prevention and treatment of infectious diseases (including tuberculosis and
HIV/AIDS), immunisation coverage, oncology, haematology and provision of
certain pharmaceuticals to eligible groups.
Around 70% of the pharmaceutical market is supplied by imports. Switzerland,
Lithuania and Germany were the leading suppliers in 2004, accounting for
almost 50% of imports. Imports have increased in value terms every year since
2001.
The European Regional Development Fund and the Latvian government are
currently funding the National Programme in the Area of Healthcare 2004-2006,
worth 11.3 million lats (US$6.1 million). The programme consists of a number
of projects aimed at improving primary healthcare. One of the objectives is to
improve the availability of good quality pharmaceutical care, medicines and
objective information regarding medicines.